Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension

    Hypertension, Volume 60, Issue 2, 2012, Pages 310-318.

    Cited by: 55|Bibtex|Views0|Links
    WOS

    Abstract:

    Azilsartan medoxomil, an effective, long-acting angiotensin II receptor blocker, is a new treatment for hypertension that is also being developed in fixed-dose combinations with chlorthalidone, a potent, long-acting thiazide-like diuretic. We compared once-daily fixed-dose combinations of azilsartan medoxomil/chlorthalidone force titrated...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments